The company will try to get the Komzifti QTc prolongation warning removed.
ApexOnco Front Page
Recent articles
It’s less about being fast, more about producing a better product.
Arcellx and AstraZeneca take centre stage.
Five years after settling, GSK is again accused of breaching the Jemperli deal.
Meanwhile, Zai Lab faces delays in its pivotal DLL3 trial.
The cash-strapped biotech adds Car-T projects but tries to avoid a lawsuit.
And AbbVie and Genmab scoop their ASH presentation with new data.
The company adds royalty aggregation to its R&D business.
